Dr. Duncan Ross, Kimera Labs: The Revolution of Exosomes Therapeutics
The strategic Science and the clinical applications of exosomes in dermatology were discussed by Dr. Duncan Ross, Kimera Labs USA, at Skin Ageing & Challenges 2022.
Exosome Therapeutics: Application of MSC Exosomes in Clinical Medicine
As presented by Kimera Labs: Research into MSC Exosomes presents a tremendous opportunity for development of biopharmaceuticals by providing a simple mechanism for delivery of therapeutic molecules.
Preclinical studies indicate that the naturally occurring proteins, messenger RNA and microRNA within MSC Exosomes improve the function of aging, injured or diseased cell, tissues and organs. Introduction of other therapeutic agents into these exosomes has also demonstrated impressive results in preclinical research. As an ideal vehicle for delivery, the lipid membrane of exosomes serves not only to protect exosome proteins and RNA from degradation, but also allows exosomes to reach cells in parts of the body that many drugs cannot. For example, exosomes are able to cross the blood-brain barrier and can penetrate solid tissue masses like the thyroid or tumors. Optimizing these properties and the contents of MSC exosomes developed for specific clinical indications may become the future of medicine.
You can still access the conference replay and abstract book in case you missed this annual meeting.
Skin Ageing & Challenges 2022
November 17-18, 2022 – Lisbon, Portugal
www.skin-challenges.com